Oxycodone DETERx, an extended-release, abuse-deterrent formulation for management of patients with chronic pain and chronic pain with dysphagia

被引：2
|
作者：
Kopecky, E. [1 ]
Fleming, A. [1 ]
Findlen, K. [1 ]
Mayock, S. [1 ]
Varanasi, R. [1 ]
Saim, S. [1 ]
机构：
[1] Coll Pharmaceu Inc, Canton, MA USA
来源：
JOURNAL OF PAIN | 2014年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jpain.2014.01.370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
459
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [1] Oxycodone DETERx®: A Novel Abuse-Deterrent, Extended-Release Analgesic Option for the Treatment of Patients with Chronic Pain
    Gudin J.
    Pain and Therapy, 2016, 5 (2) : 171 - 186
  • [2] Oxycodone DETERx, an extended-release, tamper-resistant formulation for management of chronic pain
    Kopecky, E.
    Fleming, A.
    Varanasi, R.
    Saim, S.
    Mayock, S.
    JOURNAL OF PAIN, 2013, 14 (04): : S68 - S68
  • [3] An abuse-deterrent, microsphere-in-capsule formulation of extended-release oxycodone: alternative modes of administration to facilitate pain management in patients with dysphagia
    McCarberg, Bill H.
    Kopecky, Ernest A.
    O'Connor, Melinda
    Marseilles, Ann
    Varanasi, Ravi K.
    Thompson, Christy
    Fleming, Alison B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 1975 - 1982
  • [4] Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD)
    Fleming, Alison B.
    Carlson, Douglas R.
    Varanasi, Ravi K.
    Grima, Michael
    Mayock, Stephen P.
    Saim, Said
    Kopecky, Ernest A.
    PAIN PRACTICE, 2016, 16 (03) : 334 - 344
  • [5] Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone
    Nalamachu, Srinivas
    Kopecky, Ernest A.
    Taylor, Robert, Jr.
    Vaughn, Ben
    O'Connor, Melinda
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (07) : 1311 - 1317
  • [6] Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation
    Sessler, Nelson E.
    Downing, Jerod M.
    Kale, Hrishikesh
    Chilcoat, Howard D.
    Baumgartner, Todd F.
    Coplan, Paul M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (12) : 1238 - 1246
  • [7] Novel design to evaluate the efficacy and safety of an abuse-deterrent, extended-release oxycodone product candidate in patients with moderate-to-severe chronic low back pain
    Rauck, R.
    Markman, J.
    Nalamachu, S.
    Hale, M.
    Dayno, J.
    Niebler, G.
    Lawler, J.
    Coyle, E.
    O'Brien-Giemza, J.
    Katz, N.
    JOURNAL OF PAIN, 2017, 18 (04): : S35 - S35
  • [8] The Effect of Abuse-Deterrent Extended-Release Oxycodone Leads to Inappropriate Conclusions with Over Estimation of Safety of Abuse-Deterrent Formulations
    Manchikanti, Laxmaiah
    Atluri, Sairam
    Hirsch, Joshua A.
    PAIN PHYSICIAN, 2015, 18 (03) : E445 - E446
  • [9] Abuse-deterrent extended-release oxycodone and risk of opioid-related harm
    Paljarvi, Tapio
    Strang, John
    Quinn, Patrick D.
    Luciano, Sierra
    Fazel, Seena
    ADDICTION, 2021, 116 (09) : 2409 - 2415
  • [10] The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain
    Pergolizzi, Joseph V., Jr.
    Taylor, Robert, Jr.
    Raffa, Robert B.
    ADVANCES IN THERAPY, 2015, 32 (06) : 485 - 495
12345